Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Hanwha Ocean (042660) – Kiwoom | High-Price Mix · Merchant Margin Acceleration · 2H Order Intake / 2026-07-28 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | MLCC Price Cycle · Customer Prepayments · Server Demand / 2026-08-11 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q4 2025 Earnings Presentation / 2026-01-23 IR Room
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Infrastructure · LTA · HBM Demand / 2026-06-09 Research
  • [Research] Alteogen (196170) – Hana Securities | Steady Milestone Inflows · Interpreting GSK’s Enhanze Deal · PGR Final Ruling Catalysts / 2026-05-13 Research
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor | LTA · Premium Product Mix · Blended ASP / 2026-07-14 Research
  • [Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | High-Value Order Expansion · ASP Growth · Earnings Upward Revision / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | ADR Listing · HBM Pricing · Valuation Re-rating / 2026-06-30 Research

[Research] LIG D&A (079550/KS) – SK Securities | 1Q26 Earnings Beat · Overdone Correction · Global Demand Expansion / 2026-05-08

Posted on May 8, 2026August 21, 2026 By ksb220805@gmail.com

Brokerage : SK Securities

Analyst : Shane Han, RA Seoyoung Ko

Investment Rating : BUY (Maintain)

Target Price : KRW 1,150,000 (Maintain)

Core Momentum : Substantial 1Q26 earnings beat driven by high-margin export mix, 70-80% capacity utilization headroom, and structural Q*P compounding supported by 2026-2027 CapEx investments

1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: Rating BUY (Maintain), Target Price KRW 1,150,000 (Maintain), Current Price KRW 866,000 (As of May 7, 2026), Upside Potential 32.8%
  • Valuation Methodology: Target price derived by applying a Target P/E multiple of 40x to the 2028 estimated EPS of KRW 28,481
  • 2026 Full-Year Forecasts & Consensus Comparison:
    • New Forecast: Revenue KRW 5,065 Billion, Operating Profit KRW 469 Billion (OPM 9.3%), Controlling Net Profit KRW 371 Billion (Net Margin 7.3%)
    • Consensus Comparison: Outperforming consensus estimates across Revenue (+0.3% vs. KRW 5,048 Billion), Operating Profit (+5.9% vs. KRW 443 Billion), and Controlling Net Profit (+0.5% vs. KRW 369 Billion)
    • Full-year OPM is expected to exceed the company’s conservative annual guidance of 7% (and export mix guidance of 25% or below)
  • Stock & Corporate Data: KOSPI 7,490.05pt, 52-Week High KRW 1,020,000, 60-Day Avg Daily Trading Value KRW 367 Billion, Outstanding Shares 22.0 Million shares, Market Cap KRW 19,052 Billion, Foreign Ownership 23.67%, Major Shareholders LIG & 8 affiliated parties (38.21%), National Pension Service (9.67%)

2. [Market Opportunities & Business Outlook]

  • 1Q26 Earnings Review:
    • Consolidated revenue reached KRW 1,167.9 Billion (+28.7% YoY, -16.9% QoQ) and operating profit recorded KRW 171.1 Billion (+56.1% YoY, +342.4% QoQ, OPM 14.6%), significantly beating consensus (KRW 117.3 Billion) with no one-off items.
    • Core Drivers: Early delivery of Korean military-allocated volumes to the UAE due to the Iran war context, combined with the recognition of high-margin follow-on contracts (maintenance and spare parts).
  • Market Misperceptions & Correction Context:
    • Post-earnings price correction following the maintenance of the full-year 7% OPM guidance is viewed as excessive; high interceptor consumption rates indicate potential for additional volume deliveries across remaining quarters, supporting full-year earnings above guidance.
  • Production Capacity & Pipeline Catalysts:
    • Operating at a 70–80% utilization rate, providing operational headroom for accelerated deliveries and additional orders.
    • Annual CapEx of ~KRW 300 Billion planned for both 2026 and 2027, with revenue contributions from expanded capacity expected in 2028–2029.
    • Inflow of inquiries for Cheongung-II across Middle Eastern nations, alongside growing interest for Haegung (K-SAAM) in Southeast Asia, supporting long-term volume and pricing growth to alleviate valuation burdens.

Editor’s Comment (Perspective)

The covering analyst views LIG D&A not as an enterprise constrained by conservative management guidance (7%), but as an agile defense leader positioned for sustained compounding driven by proven profitability in follow-on support contracts and ample 70–80% utilization headroom. This perspective places primary importance on potential follow-on deliveries across 2026, the KRW 600 Billion total CapEx expansion across 2026–2027, and expanding pipelines for Cheongung-II across Middle Eastern nations and Haegung in Southeast Asia over near-term market sentiment swings.

To verify whether this investment thesis continues to materialize, primary focus should be directed toward sustaining high export profitability across remaining quarters to achieve the projected 9.3% full-year OPM, contract awards for Cheongung-II in the Middle East and Haegung in Southeast Asia, and the execution progress of the 2026–2027 manufacturing capacity expansions. These operational milestones can be monitored through upcoming quarterly earnings releases, corporate IR disclosures, contract award filings, and official periodic reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Defense

Post navigation

Previous Post: [Research] LIG D&A (079550) – Eugene Investment & Securities | Non-Cheongung Potential · High-margin Legacy Defense · Earnings Surprise / 2026-05-08
Next Post: [Research] LIG D&A (079550) – Shinhan Securities | 1Q26 Surprise · Demand Surge · Long-term Compounding / 2026-05-08

Related Posts

  • [Research] Celltrion (068270) – iM Securities | New Product Mix Expansion · First-Mover Advantage · Two-Track Long-Term Strategy / 2026-07-28 Research
  • [Research] LIG D&A (079550) – Yuanta Securities | Cheongung-II Demand Surge · OPM Guidance Upgrade · Middle East Overlap / 2026-08-07 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | Hypothetical SDC Stake Monetization · North American ESS Acceleration · Valuation Appeal / 2026-01-19 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | DRAM Supply Shortage · Supplier Pricing Power · HBM3E / 2026-01-05 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | AI Server Demand · Memory ASP · High-Value Product Mix / 2026-01-30 Research
  • [Research] Hanwha Ocean (042660) – Shinhan | Merchant Profit Level-Up · Special Ship Order Variables · Balanced Portfolio / 2026-07-28 Research
  • [Research] SK hynix (000660 / SKHY) – IBK Securities | AI Servers · Server DRAM · Supply Tightness / 2026-04-15 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | Peptide Market Entry · Global Footprint Expansion · Modality Diversification / 2026-07-21 Research
  • [Research] Hanwha Ocean (042660) – Kiwoom | High-Price Mix · Merchant Margin Acceleration · 2H Order Intake / 2026-07-28 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Hyperscaler Capex · Custom HBM · Inference Memory Demand / 2026-05-04 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | DRAM Supply-Demand · AI Infrastructure Finance · Valuation Re-rating / 2026-08-14 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 Research
  • [Research] LIG D&A (079550) – Yuanta Securities | Cheongung-II Demand Surge · OPM Guidance Upgrade · Middle East Overlap / 2026-08-07 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme